Austrian authorities have suspended inoculations with a batch of AstraZeneca’s COVID-19 vaccine as a precaution whereas investigating the death of one person and also the illness of another when the shots, a health agency said on Sunday.
The authorities took this decision as an individual in Austria died shortly once receiving the vaccine dose, as per media reports.
“The Federal Office for Safety in Health Care (BASG) has received 2 reports in a temporal connection with a vaccination from the identical batch of the AstraZeneca vaccine in the district clinic of Zwettl” in Lower Austria province, it said.
One 49-year-recent woman died as a result of severe coagulation disorders, whereas a 35-year-previous lady developed a pulmonary embolism and is recovering, it said. A pulmonary embolism is an acute lung disease caused by a dislodged blood clot.
“Currently there is no proof of a causal relationship with the vaccination,” BASG said.
According to the native media, Niederosterreichische Nachrichten, broadcaster ORF, and also the APA news agency, the ladies who faced abnormal outcomes when vaccine doses were both nurses at the Zwettl clinic.
The state health agency maintained that the blood clot is not an outcome of the vaccine facet effects. Hence, they’re investigating the matter.
“As a precautionary measure, the remaining stocks of the affected vaccine batch are now not being issued or vaccinated,” it added.
The APA news agency additionally cited AstraZeneca that said it is cooperating with Austrian authorities within the investigation of those cases.
“All of these evaluations have concluded that the AstraZeneca Covid-19 vaccine is safe and effective,” APA quoted the company as saying.
European Union regulators on Jan. 30 approved the merchandise, saying it was effective and safe to use. Adverse reactions seen in trials were short-lived for the foremost part and blood clotting problems were not reported.
(Except for the headline, this story is published from a syndicated feed.)